Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells: Comparative studies with transforming growth factor β1

British Journal of Haematology

Volumn 93, Issue 2, 1996, Pages 265-272

  Xi, Xiaodong ^a,b   Caen, Jacques P ^a   Fournier, Sylvie ^b   Schlegel, Nicole ^b   Amiral, Jean ^c   Sibony, Olivier ^b   Blot, Philippe ^b   Han, Zhong C ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c Serbio   (France)

Author keywords

CD34+ cells; inhibition; megakaryocytopoiesis; platelet factor 4; reversible

Indexed keywords

CD34 ANTIGEN; FLUOROURACIL; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; THROMBOCYTE FACTOR 4;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOPOIESIS; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0029933346     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.4901032.x     Document Type: Article

References (31)

1. Aidoudi, S., Guigon, M. Caen, J.P. & Han, Z.C. (1994) Seraspenide and platelet factor 4 (PF4) protect murine hematopoietic stem cells from the toxicity of 5-fluorouracil (5-FU). (Abstract). XXV Congress of the International Society of Hematology, p. 190.
2. Amiral, J., Bridey, F., Wolf, M., Boyer-Neumann, C., Fressinaud, E., Vissac, A.M., Peynaud-Debayale, E., Dreyfus, M. & Meyer, D. (1995) Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thrombosis and Haemostasis, 73, 21-28.
3. Avraham, H., Vannier, E., Cowley, S., Jiang, J., Chi, S., Dinarello, C.A., Zsebo, K.M. & Groopman, J.E. (1992) Effects of the stem cell factor, c-kit ligand, on the megakaryocytic cells. Blood, 79, 365-371.
4. Briddell, R.A., Broudy, V.C., Bruno, E. Brandt, J.E. Srour, E.F. & Hoffman, R. (1992) Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood, 79, 3159-3167.
5. Briddell, R.A., Bruno, E. Cooper, R.J., Brandt, J.E. & Hoffman, R. (1991) The effect of c-kit ligand on in vitro human megakaryopoiesis. Blood, 78, 2854-2859.
6. Broxmeyer, H.E., Hangoc, G., Cooper, S., Ribeiro, R.C., Graves, V., Yoder, M., Wagner, J., Vadhan-Raj, S., Benninger, L., Rubinstein, P. & Broun, E.R. (1992) Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proceedings of the National Academy of Sciences of the United States of America, 89, 4109-4113.
7. Chenaille, P.J., Steward, S.A., Ashmun, R.A. & Jackson, C.W. (1990) Prolonged thrombocytosis in mice after 5-fluorouracil results from failure to downregulation megakaryocyte concentration: an experimental model that dissociates regulation of megakaryocyte size and DNA content from megakaryocyte concentration. Blood, 76, 508-515.
8. Debili, N., Hegyi, E., Navarro, S., Katz, A., Mouthon, M.-A., Breton-Gorius, J. & Vainchenker, W. (1991) In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes. Blood, 77, 2326-2338.
9. Gewirtz, A.M., Calabretta, B., Rucinski, B., Niewiarowski, S. & Xu, W.Y. (1989) Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. Journal of Clinical Investigation, 83, 1477-1486.
10. Gupta, S.K. & Singh, J.P. (1994) Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. Journal of Cell Biology, 127, 1121-1127.
11. Han, Z.C. (1994) Identification of a murine high-proliferative-potential colony-forming cell (HPP-CFC) capable of producing a number of megakaryocytes and replating for secondary HPP-CFCs in culture. Journal of Laboratory and Clinical Medicine, 123, 610-616.
12. Han, Z.C., Bellucci, S., Bodevin, E. Wan, H.Y., Shen, Z.X. & Caen, J.P. (1991) In vivo inhibition of megakaryocyte and platelet production by platelet factor 4 in mice. Comptes Rendu de l'Académie de Sciences, Paris, 313, 553-558.
13. Han, Z.C., Bellucci, S., Tenza, D. & Caen, J.P. (1990a) Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura. British Journal of Haematology, 74, 395-401.
14. Han Z.C., Bellucci, S., Walz, A., Baggiolini, M. & Caen, J.P. (1990b) Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4), and connective tissue-activating peptide III (CTAP-III). International Journal of Cell Cloning, 8, 253-259.
15. Han, Z.C., Bellucci, S., Wan, H.Y. & Caen, J.P. (1992a) New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblast growth factors and transforming growth factor β1. British Journal of Haematology, 81, 1-5.
16. Han, Z.C., Brière, J., Abgrall, J.F., Sensébe, L., Parent, D. & Guern, G. (1989) Characteristics of megakaryocyte colony formation in normal individuals and in primary thrombocythemia: studies using an optimal cloning system. Experimental Hematology, 17, 46-52.
17. Han, Z.C. & Caen, J.P. (1993) Are megakaryocytes and endothelial cells sisters? Journal of Laboratory and Clinical Medicine, 121, 821-825.
18. Han, Z.C., Maurer, A.M., Bellucci, S., Wan, H.Y., Kroviarski, Y., Bertrand, O. & Caen, J.P. (1992b) Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4. Journal of Laboratory and Clinical Medicine, 120, 645-660.
19. Han, Z.C., Sensébe, L., Abgrall, J.F. & Brière, J. (1990c) Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood, 75, 1234-1259.
20. + positive hemopoietic cells: biology and clinical applications. Blood Reviews, 8, 113-124.
21. Ishibashi, T., Miller, S.L., & Burnstein, S.A. (1987) Type β transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro. Blood, 69, 1737-1741.
22. Keller, J.R., McNiece, I.K., Still, K.T., Ellingsworth, L.R., Quesenberry, P.J., Sing, G.K. & Ruscetti, F.W. (1990) Transforming growth factor β directly regulatrs primitive murine hematopoietic cell proliferation. Blood, 75, 596-602.
23. Kuter, D.J., Gminski, D.M. & Rosenberg, R.D. (1992) Transforming growth factor β inhibits megakaryocyte growth and endomitosis. Blood, 79, 619-626.
24. Mayani, H., Dragowska, W. & Lansdorp, P.M. (1993a) Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells. Blood, 81, 3252-3258.
25. + cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines. Blood, 82, 2664-2672.
26. Mitjavila, M.T., Vinci, G., Villeval, J.L., Kieffer, M., Henri, A., Testa, U., Breton-Gorius, J. & Vainchenker, W. (1988) Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type B transforming growth factor (TCF-β). Journal of Cellular Physiology, 134, 93-100.
27. Simmons, P.J., Aylett, G.W., Niutta, S., To, L.B., Juttner, C.A. & Ashman, L.K. (1994) c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Experimental Hematology, 22, 157-165.
28. + cells. Leukemia, 6, 845-852.
29. + cells an enhanced ex vivo expansion potential. Experimental Hematology, 22, 1264-1272.
30. Xi, X., Schlegel, N., Caen, J.P., Minty, A., Fournier, S., Caput, D., Ferrara, P. & Han, Z.C. (1995) Differential effects of recombinant human interleukin-13 on the in vitro growth of haemopoietic progenitor cells. British Journal of Haematology, 90, 921-927.
31. Zucker-Franklin, D., Yang, J.-S. & Grusky, G. (1992) Characterization of glycoprotein IIb/IIIa cells in human umbilical cord blood: their potential usefulness as megakaryocyte progenitors. Blood, 79, 347-355.